Dublin, Jan. 06, 2017 -- Research and Markets has announced the addition of the "Prefilled Syringes Market by Material (Glass, Plastic), Type (Conventional, Safety), Design (Dual & Single-Chamber, Customized ), Region (North America (U.S.), Europe (Germany, UK, France), Asia-Pacific (Japan, India, China)) - Forecast to 2021" report to their offering.
The Prefilled Syringes Market is Expected to Reach USD 6.36 Billion by 2021, at a CAGR of 10.1% From 2016 to 2021
In this report, the prefilled syringes market has been segmented on the basis of material (glass prefilled syringes and plastic prefilled syringes), type (conventional prefilled syringes and safety prefilled syringes), design (single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes) and region.
The growth of the overall prefilled syringes market is driven by factors such as increasing technological advancements in prefilled syringes, high prevalence of chronic diseases, rising adoption of self-injection devices, and implementation of needlestick legislations. In addition, growing initiatives undertaken by leading market players to establish production facilities in both mature and developing markets are further adding to the growth prospects of this market.
On the other hand, the low market presence of prefilled syringes with integrated safety features and product recalls are the major factors limiting the growth of this market. Furthermore, availability of cheaper alternatives and challenges associated with the manufacturing of prefilled syringes are the key challenges faced by companies in the global prefilled syringes market.
The prefilled syringes market is highly competitive including large, medium-sized, and small companies. In 2015, the prefilled syringes market was dominated by Gerresheimer AG (Germany), SCHOTT AG (Germany), and Becton, Dickinson and Company (U.S.). Expansions, partnerships, and acquisitions were the major strategies adopted by most market players between 2013 and 2016 to achieve growth in the prefilled syringes market.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Prefilled Syringes Market, by Material
7 Prefilled Syringes Market, by Type
8 Prefilled Syringes Market, by Design
9 Prefilled Syringes Market, by Region
10 Competitive Landscape
11 Company Profiles
- Becton, Dickinson And Company
- Catalent, Inc.
- Gerresheimer AG
- Medpro Inc.
- Nipro Corporation
- OMPI (A Stevanato Group Company)
- Schott AG
- Vetter Pharma International Gmbh
- Weigao Group
- West Pharmaceutical Services, Inc.
For more information about this report visit http://www.researchandmarkets.com/research/j4pblx/prefilled
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infusions and Injectables , Needles and Syringes


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



